CollPlant Biotechnologies Ltd.

CLGN | NASDAQ | 0 Obserwujący

$1.42

-15.48%

-$0.26

Obserwuj

Overview Metrics Financials

Breakdown	12/31/2024 USD	12/31/2023 USD	12/31/2022 USD	12/31/2021 USD
Total revenue	515 -95.30%	10,959 +3,565.22%	299 -98.09%	15,641 -
Cost of revenue	1,625 -18.38%	1,991 +397.75%	400 -80.05%	2,005 -
Gross profit	-1,110 -112.38%	8,968 +8,979.21%	-101 -100.74%	13,636 -
Operating expense	16,141 -2.06%	16,480 -3.04%	16,996 +25.24%	13,571 -
Operating income	-17,251 -129.65%	-7,512 +56.06%	-17,097 -26,403.08%	65 -
Pretax Income	-16,609 -136.63%	-7,019 +58.53%	-16,925 -7,241.35%	237 -
Tax Provision	0 -	0 +100.00%	-172 0.00%	-172 -
Net income	-16,609 -136.63%	-7,019 +58.10%	-16,753 -4,196.09%	409 -
EPS	-1.45 -133.87%	-0.62 +59.21%	-1.52 -3,807.32%	0.04 -
Diluted EPS	-1.45 -133.87%	-0.62 +59.21%	-1.52 -4,544.44%	0.03 -
Average Shares	11,455 +0.57%	11,389 +3.23%	11,033 +10.68%	9,969 -
Diluted Average Shares	11,455 +0.57%	11,389 +3.23%	11,033 -7.80%	11,967 -
EBIT	-17,251 -129.65%	-7,512 +56.06%	-17,097 -26,403.08%	65 -
EBITDA	-16,213 -152.93%	-6,410 +59.99%	-16,021 -2,011.81%	838 -

Używamy ciasteczek, aby ulepszyć Twoje doświadczenie na naszej stronie.